Calendar Recursion Pharmaceuticals, Inc.

Equities

RXRX

US75629V1044

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 23/06/2025 BST			Pre-market 01:00:00
4.830 ^USD	-3.98%		4.910	+1.66%

06-19	Recursion Pharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 10:00 AM
06-16	Morgan Stanley Cuts Recursion Pharmaceuticals Price Target to $5 From $8, Maintains Equalweight Rating	MT

Chart calendar Recursion Pharmaceuticals, Inc.

fb41.o3tP5I8_hbCW0Bk8hyPVwSdoYGviP8u-ShQaivivOt8.-UICtcAS3ebQuFpbzRSzr2AQJw6yDLnLBlF5ya76U6yOQ32G0GDO2sWeeg~1dcd84e9bddff548e7ac20f47d6e4795

Upcoming events on Recursion Pharmaceuticals, Inc.

11/08/2025	Q2 2025 Earnings Release (Projected)
04/11/2025	Q3 2025 Earnings Release (Projected)
03/03/2026	Q4 2025 Earnings Release (Projected)
10/05/2026	Q1 2026 Earnings Release (Projected)

Past events on Recursion Pharmaceuticals, Inc.

22/06/2025	TDCowen Tools/Dx Revolution Conference
18/06/2025 19:00	Annual General Meeting
10/06/2025 20:20	Goldman Sachs Global Healthcare Conference
05/06/2025 19:00	Jefferies Healthcare Conference
15/05/2025 15:00	J.P. Morgan Global Technology, Media and Communications Conference
13/05/2025 18:00	Bank of America Global Healthcare Conference
05/05/2025 13:00	Q1 2025 Earnings Call
05/05/2025 11:00	Q1 2025 Earnings Release
04/05/2025 17:15	Digestive Disease Week Conference - Presentation ID: 354a
07/04/2025 13:00	Needham Healthcare Conference
28/02/2025 13:30	Q4 2024 Earnings Call
28/02/2025 11:30	Q4 2024 Earnings Release
13/01/2025 15:30	JP Morgan Healthcare Conference
09/12/2024	American Association for Cancer Research Special Conference
20/11/2024 13:00	Jefferies London Healthcare Conference
20/11/2024 12:30	Business Update Call
12/11/2024 22:00	Extraordinary Shareholders Meeting
06/11/2024 21:15	Q3 2024 Earnings Release
08/08/2024 13:30	Q2 2024 Earnings Call
08/08/2024 12:30	Q2 2024 Earnings Release

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	39,8 51,2 -22.25%	44,6 52,1 -14.47%	58,8 67,8 -13.22%	71,0	107	219
EBITDA Million USD	Released Forecast Spread	-234 -256 8.74%	-326 -307 -6%	-443 -395 -12.08%	-532	-448	-390
EBIT Million USD	Released Forecast Spread	-246 -227 -8.46%	-350 -342 -2.41%	-479 -411 -16.62%	-558	-459	-416
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-239 -216 -11.13%	-332 -329 -0.81%	0,00 0,00 -	0,00	0,00	0,00
Net income Million USD	Released Forecast Spread	-239 -226 -6.11%	-328 -333 1.49%	-464 -418 -10.85%	-531	-412	-142
EPS USD	Released Forecast Spread	-1,36 -1,39 2.44%	-1,58 -1,66 5.01%	-1,69 -1,60 -5.93%	-1,45	-1,11	-0,30
Announcement Date		27/02/23	27/02/24	28/02/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	10,5 12,9 -18.16%	10,9 20,4 -46.49%	13,8 13,1 5.57%	14,4 13,3 8.52%	26,1 29,8 -12.56%	4,55 19,0 -76.13%	14,7 18,1 -18.46%	16,2	20,0	23,2	16,4	15,3	22,6	22,8
EBITDA Million USD	Released Forecast Spread		-91,4 -85,5 -6.87%	-89,0 -91,3 2.56%	-91,6 -89,0 -2.89%	-91,2 -86,5 -5.38%		-172 -247 30.35%	-123	-111	-130	-102	-101	-81,6	-104
EBIT Million USD	Released Forecast Spread	-99,6 -81,9 -21.57%	-98,9 -87,9 -12.52%	-96,3 -100 3.73%	-101 -101 0.51%	-98,4 -93,1 -5.68%	-184 -123 -49.21%	-191 -184 -3.92%	-139	-129	-127	-125	-115	-106	-105
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-93,0 -82,0 -13.44%	-94,6 -94,4 -0.24%	-92,2 -106 13.06%	-98,1 -84,0 -16.81%	-95,7 -84,8 -12.89%	-179 -104 -72.02%
Net income Million USD	Released Forecast Spread	-93,0 -77,5 -20.01%	-93,0 -96,7 3.87%	-91,4 -98,9 7.63%	-97,5 -91,7 -6.37%	-95,8 -88,2 -8.66%	-179 -135 -32.33%	-202 -187 -8.26%	-123	-120	-110	-108	-105	-91,1	-101
EPS USD	Released Forecast Spread	-0,43 -0,38 -12.99%	-0,42 -0,45 6.69%	-0,39 -0,42 6.25%	-0,40 -0,38 -6.35%	-0,34 -0,35 3.01%	-0,53 -0,46 -16.01%	-0,50 -0,56 10.18%	-0,32	-0,29	-0,28	-0,27	-0,26	-0,25	-0,25
Announcement Date		09/11/23	27/02/24	09/05/24	08/08/24	06/11/24	28/02/25	05/05/25	-	-	-	-	-	-	-

Upcoming sector events for Recursion Pharmaceuticals, Inc.

02/07/2025	KALVISTA PHARMACEUTICALS, INC.: Q4 2025 Earnings Release (Projected)
09/07/2025	NURIX THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
22/07/2025	VIKING THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
23/07/2025	BIOCON LIMITED: Q1 2026 Earnings Release (Projected)
29/07/2025	CASSAVA SCIENCES, INC.: Q2 2025 Earnings Release (Projected)
29/07/2025	XENCOR, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	DYNE THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	KURA ONCOLOGY, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	SANA BIOTECHNOLOGY, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	KEROS THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Recursion Pharmaceuticals, Inc.

12/06/2025	SANBIO COMPANY LIMITED: Q1 2025 Earnings Release
09/06/2025 07:46	LUMOSA THERAPEUTICS CO., LTD.: May 2025 Sales and Revenue Release
05/06/2025 09:21	PHARMAESSENTIA CORPORATION: May 2025 Sales and Revenue Release
15/05/2025 13:00	TAYSHA GENE THERAPIES, INC.: Q1 2025 Earnings Release
14/05/2025	LIGACHEM BIOSCIENCES INC.: Q1 2025 Earnings Release
14/05/2025	PEPTRON, INC.: Q1 2025 Earnings Release
14/05/2025	OLIX PHARMACEUTICALS, INC: Q1 2025 Earnings Release
14/05/2025 21:05	ENLIVEN THERAPEUTICS, INC.: Q1 2025 Earnings Release
14/05/2025 12:00	SCHOLAR ROCK HOLDING CORPORATION: Q1 2025 Earnings Release
14/05/2025 02:00	BELITE BIO, INC: Q1 2025 Earnings Release